Erin Peregrine Antalis

Erin Peregrine Antalis is a seasoned professional in clinical research and management with a diverse background in oncology, public health, and academia. Currently serving as a Clinical Risk Manager at ICON plc since March 2022, Erin previously held roles as a Clinical Trial Manager at Adjuvance Technologies Inc. and as a Research Manager for the Sarcoma Alliance for Research Through Collaboration, overseeing multiple phases of clinical trials. Erin's experience also includes managing the Sarcoma Survivorship Program at the University of Michigan Medical School and engaging in community outreach for Hepatitis C treatment at the University of Illinois at Chicago, where teaching roles in anthropology and public health were also undertaken. Educational accomplishments include a PhD in Anthropology and a Masters in Public Health from the University of Illinois Chicago, alongside a Bachelor's degree in Literature from Florida State University.